TIMP1 Gene Bicuspid Aortic Valve Genetic Test
Are you concerned about the risk of developing bicuspid aortic valve (BAV)? DNA Labs UAE offers the TIMP1 Gene Bicuspid Aortic Valve Genetic Test to provide you with valuable insights into your genetic makeup and potential predisposition to this congenital heart defect.
Test Components
- Price: 4400.0 AED
- Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
- Report Delivery: 3 to 4 Weeks
- Method: NGS Technology
- Test Type: Cardiovascular Pneumology Disorders
- Doctor: Cardiologist
- Test Department: Genetics
Pre Test Information
Prior to undergoing the TIMP1 Gene Bicuspid Aortic Valve Genetic Test, it is essential to provide the clinical history of the patient. Additionally, a genetic counseling session will be conducted to draw a pedigree chart of family members affected by the TIMP1 Gene Bicuspid Aortic Valve NGS Genetic DNA Test gene TIMP1.
Test Details
The TIMP1 gene is responsible for encoding the tissue inhibitor of metalloproteinase 1, a protein involved in regulating matrix metalloproteinases (MMPs). MMPs are enzymes that break down components of the extracellular matrix and have been linked to various diseases, including cardiovascular diseases.
Bicuspid aortic valve (BAV) is a congenital heart defect characterized by the presence of only two leaflets in the aortic valve, instead of the normal three. BAV is associated with an increased risk of developing aortic valve stenosis (narrowing of the valve) and aortic valve regurgitation (leakage of blood back into the left ventricle).
NGS (next-generation sequencing) genetic testing is a state-of-the-art technique that allows for the simultaneous sequencing of multiple genes or even the entire genome. This advanced technology enables the identification of genetic variants, including single nucleotide polymorphisms (SNPs) and small insertions or deletions, that may be associated with a particular disease or condition.
In the context of bicuspid aortic valve, NGS genetic testing can be utilized to identify genetic variants in the TIMP1 gene that may contribute to the development or progression of the disease. This valuable information can enhance our understanding of the underlying mechanisms of BAV and potentially predict the risk of developing complications associated with the condition.
It is important to note that genetic testing alone may not be sufficient to diagnose or predict the development of bicuspid aortic valve. Clinical evaluation and imaging studies are typically used in conjunction with genetic testing to provide a comprehensive diagnosis and assessment of the condition.
Don’t let uncertainty weigh on your mind. Take control of your health with the TIMP1 Gene Bicuspid Aortic Valve Genetic Test from DNA Labs UAE. Contact us today to schedule an appointment and gain valuable insights into your genetic predisposition for this congenital heart defect.
| Test Name | TIMP1 Gene Bicuspid aortic valve Genetic Test |
|---|---|
| Components | |
| Price | 4400.0 AED |
| Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card |
| Report Delivery | 3 to 4 Weeks |
| Method | NGS Technology |
| Test type | Cardiovascular Pneumology Disorders |
| Doctor | Cardiologist |
| Test Department: | Genetics |
| Pre Test Information | Clinical History of Patient who is going for TIMP1 Gene Bicuspid aortic valve NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with TIMP1 Gene Bicuspid aortic valve NGS Genetic DNA Test gene TIMP1 |
| Test Details | The TIMP1 gene is a gene that encodes for tissue inhibitor of metalloproteinase 1, which is a protein involved in the regulation of matrix metalloproteinases (MMPs). MMPs are enzymes that break down components of the extracellular matrix, and their dysregulation has been implicated in various diseases, including cardiovascular diseases. Bicuspid aortic valve (BAV) is a congenital heart defect characterized by the presence of only two leaflets in the aortic valve, instead of the normal three. BAV is associated with an increased risk of developing aortic valve stenosis (narrowing of the valve) and aortic valve regurgitation (leakage of blood back into the left ventricle). NGS (next-generation sequencing) genetic testing is a type of genetic test that allows for the simultaneous sequencing of multiple genes or even the entire genome. It enables the identification of genetic variants, including single nucleotide polymorphisms (SNPs) and small insertions or deletions, that may be associated with a particular disease or condition. In the context of bicuspid aortic valve, NGS genetic testing can be used to identify genetic variants in the TIMP1 gene that may be involved in the development or progression of the disease. This information can be useful for understanding the underlying mechanisms of BAV and potentially for predicting the risk of developing complications associated with the condition. It is important to note that genetic testing alone may not be sufficient to diagnose or predict the development of bicuspid aortic valve. Other factors, such as clinical evaluation and imaging studies, are typically used in conjunction with genetic testing to make a comprehensive diagnosis and assessment of the condition. |
